CD4 and neoplasm: Regarding tumor-specific responses, the percentages of CD4+ T cells (Figure 5D), CD8+ T cells (Figure 5E), and memory T cells (Figure 5F) were increase significantly in the TA-loaded-DC vaccination groups compared to the group administered Rv2299c alone.